FAMCICLOVIR GenPar famciclovir 250 mg tablet blister pack

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

famciclovir, Quantity: 250 mg

から入手可能:

Arrotex Pharmaceuticals Pty Ltd

INN（国際名）:

Famciclovir

医薬品形態:

Tablet, film coated

構図:

Excipient Ingredients: copovidone; crospovidone; sodium stearylfumarate; silicon dioxide; microcrystalline cellulose; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate

投与経路:

Oral

パッケージ内のユニット:

3 tablets, 20 tablets, 56 tablets, 21 tablets, 5 tablets, 30 tablets, 14 tablets

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours.,Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. Famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,Famciclovir is also indicated for suppression of recurrent genital herpes.,Famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,Famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex

製品概要:

Visual Identification: White, round, coated tablets debossed with FM on one side and 250 on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Licence status A

承認日:

2017-02-24